ATNX

Athenex Inc

Last Updated:

Q3 '20

Price

quotes and stock data delayed 15 minutes

Cash

$116.3M

Burn Rate (Qtr)

$36.8M

Company Profile

Athenex is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. Our mission is to become a global leader in bringing innovative cancer treatments to the market and improve health outcomes. To achieve this, we have assembled an experienced leadership team and have established global operations across the pharmaceutical value chain.

Drug Pipeline

Click on drug name or indication to see upcoming trial info, prior data, and more general information

Drug | Disease (links)

Stage (next event)

Catalyst Date

Tirbanibulin ointment

Actinic keratosis

PDUFA

December 30, 2020

Oraxol

Metastatic Breast Cancer

PDUFA

February 28, 2021

Oraxol

Angiosarcoma

Phase 2

TBD

Oratecan

Solid Tumors

Phase 1

TBD

Pegtomarginase (PT01)

Multiple Tumors

Phase 1

TBD

KX2-361

Glioblastoma

Phase 1

TBD

Oraxol with pembrolizumab

Solid Tumors

Phase 1 Expansion Enrollment

TBD

Eribulin ORA

Solid Tumors

Phase 1

TBD

Oratopo

Solid Tumors

Phase 1

TBD

Tirbanibulin ointment

Psoriasis

Phase 1

TBD

Oradoxel

Solid Tumors

Phase 1

TBD

Oraxol with ramucirumab

Gastric cancer

Phase 1b

TBD

Tirbanibulin oral

Liquid Tumors

Pre-Clinical

TBD

Tirbanibulin oral

Ovarian Cancer

Pre-Clinical

TBD

Tirbanibulin ointment

Skin Cancers

Phase 1 initiation

TBD

TAEST16001

Mutiple Tumors

Pre-Clinical

TBD

ATNX-04

Multiple Tumors

Pre-Clinical

TBD

Recent Posts

See what the community is saying - click to see full post

ATNX - Athenex, Inc. Reports Third Quarter Ended September 30, 2020 Financial Results and Provides Corporate U

ATNX - Athenex, Inc. to Report Third Quarter 2020 Earnings Results on November 5, 2020

Will ATNX stock price pop if Oraxol gets approved?

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon